Intrauterine contraception as an alternative to interval tubal sterilization.

Knowledge and attitudes about long-acting reversible contraception among Latina women who desire sterilization. Womens Health Issues (2013) 0.84

Exploring factors in the decision to choose sterilization vs alternatives in rural El Salvador. Medscape J Med (2008) 0.80

Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system. Patient Prefer Adherence (2008) 0.79

Re: Intrauterine contraception as an alternative to interval tubal sterilization. Contraception (2008) 0.75

Knowledge and Training of Intrauterine Devices Among Primary Care Residents: Implications for Graduate Medical Education. J Grad Med Educ (2015) 0.75

Lidocaine-Prilocaine Cream as Analgesia for IUD Insertion: A Prospective, Randomized, Controlled, Triple Blinded Study. Glob J Health Sci (2015) 0.75

Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial. Obstet Gynecol (2014) 2.01

Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder. Menopause (2011) 1.50

Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception (2005) 1.21

Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev (2012) 1.20

The postpartum visit: it's time for a change in order to optimally initiate contraception. Contraception (2008) 1.10

Contraception technology: past, present and future. Contraception (2012) 1.06

Incisional endometriomas after Cesarean section: a case series. J Reprod Med (2007) 1.04

Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera. Contraception (2004) 0.98

The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status. Menopause (2008) 0.95

Increased prevalence of interstitial cystitis in women with detrusor overactivity refractory to anticholinergic therapy. Urology (2005) 0.92

A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Hum Reprod (2002) 0.90

Decreased rate of obstetrical anal sphincter laceration is associated with change in obstetric practice. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.89

Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial. Contraception (2005) 0.86

Effect of protease inhibitors on steady-state pharmacokinetics of oral norethindrone contraception in HIV-infected women. J Acquir Immune Defic Syndr (2014) 0.86

Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate. Contraception (2008) 0.85

The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction. Eur J Contracept Reprod Health Care (2012) 0.83

Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives. Contraception (2012) 0.83

Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously. Contraception (2010) 0.81

Comparison of cervical mucus of 24/4 vs. 21/7 combined oral contraceptives. Contraception (2012) 0.80

Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen. Contraception (2005) 0.80

Breastfeeding and contraception use among women with unplanned pregnancies less than 2 years after delivery. Int J Gynaecol Obstet (2009) 0.79

Vaginal rings delivering progesterone and estradiol may be a new method of hormone replacement therapy. Fertil Steril (2002) 0.78

Management of patients with interstitial cystitis or chronic pelvic pain of bladder origin: a consensus report. Curr Med Res Opin (2005) 0.77

Breaking the cycle of pain in interstitial cystitis/painful bladder syndrome: toward standardization of early diagnosis and treatment: consensus panel recommendations. J Reprod Med (2009) 0.77

Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrel. Contraception (2012) 0.77

Temporal changes in cervical mucus after insertion of the levonorgestrel-releasing intrauterine system. Contraception (2012) 0.77

Effects of progestin-only long-acting contraception on metabolic markers in obese women. Contraception (2013) 0.76

In reply. Obstet Gynecol (2014) 0.75

Effect of hormonal contraceptives during breastfeeding on infant's milk ingestion and growth. Fertil Steril (2013) 0.75

Validation of Spanish version of Pelvic Pain and Urgency/Frequency (PUF) patient symptom scale. Urology (2005) 0.75

Introduction to Population Council Symposium articles. Contraception (2010) 0.75

Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen. Contraception (2005) 0.75

Intrauterine contraception: an under-utilized method of family planning. Eur J Contracept Reprod Health Care (2007) 0.75

Pharmacological female contraception: an overview of past and future use. Expert Opin Investig Drugs (2005) 0.75